Skip to content

Clinical trials

Phase 2/3 Dermatomyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Phase: Phase 2/3 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20071
20111
20141
20151
20171
20212
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Alexion Pharmaceuticals, Inc.1
Boston Children's Hospital1
Cabaletta Bio1
Children's Hospital Medical Center, Cincinnati1
National Institute of Environmental Health Sciences (NIEHS)1
Northwell Health1
Restem, LLC.1
Royal Brompton & Harefield NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis14
Myositis8
Polymyositis8
Lung Diseases, Interstitial3
Mixed Connective Tissue Disease3
Connective Tissue Diseases2
Myositis, Inclusion Body2
Scleroderma, Diffuse2
Arthritis, Juvenile1
Arthritis, Rheumatoid1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.